(S)-4-Amino-5-phenoxypentanoate as a Selective Agonist of the Transcription Factor GabR

NIAID Data Ecosystem2026-05-01 收录

GabR激动剂

转录因子靶向

数据链接：

https://www.rcsb.org/structure/6UXZ 数据链接链接失效反馈

官方服务：

资源简介：

(S)-4-Amino-5-phenoxypentanoate as a Selective Agonist of the Transcription Factor GabR

创建时间：

2024-04-03

THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors

T细胞淋巴瘤

转录因子靶向

Peripheral T-cell lymphomas (PTCL) are aggressive diseases with poor response to chemotherapy and dismal survival. Identification of effective strategies to target PTCL biology represents an urgent ne

NIAID Data Ecosystem70

Table2_Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19.XLSX

细胞因子治疗

转录因子靶向

Treatment of the cytokine release syndrome (CRS) has become an important part of rescuing hospitalized COVID-19 patients. Here, we systematically explored the transcriptional regulators of inflammator

NIAID Data Ecosystem30

Overexpression of lung developmental transcription factors TTF-1, NKX2-8 and PAX9

肺癌预后

转录因子靶向

We investigated the clinical implications of lung developmental transcription factors (TTF-1, NKX2-8, and PAX9) which we recently discovered as cooperating oncogenes activated by way of gene amplifica

NIAID Data Ecosystem10

急性肾损伤

转录因子靶向

Treatment for acute kidney injury (AKI) is suboptimal. A better understanding of its pathogenesis may lead to new therapeutic approaches. Kidney transcriptomics analyses of murine folic acid-induced A

NIAID Data Ecosystem30

The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression

癌症生物标志物

转录因子靶向

The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression

ChEBI2012-05-17 更新10